Yüklüyor......
Serum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B
BACKGROUND & AIM: Due to known limitations of liver biopsy, reliable non-invasive serum biomarkers for chronic liver diseases are needed. We performed serum peptidomics for such investigation in compensated chronic hepatitis B (CHB) patients. METHODS: Liquid chromatography combined with tandem m...
Kaydedildi:
Asıl Yazarlar: | , , , , , , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3851457/ https://ncbi.nlm.nih.gov/pubmed/24289155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-234 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|